Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation

被引:249
作者
Tao, J
Van Esch, H
Hagedorn-Greiwe, M
Hoffmann, K
Moser, B
Raynaud, M
Sperner, J
Fryns, JP
Schwinger, E
Gécz, J
Ropers, HH
Kalscheuer, VM
机构
[1] Max Planck Inst Mol Genet, D-14195 Berlin, Germany
[2] Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium
[3] Inst Human Genet Lubeck, Lubeck, Germany
[4] Univ Lubeck, Sch Med, Dept Pediat, Lubeck, Germany
[5] CHU Bretonneau, INSERM, U316, Serv Genet, F-37044 Tours, France
[6] Womens & Childrens Hosp, Adelaide, SA, Australia
[7] Univ Adelaide, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1086/426460
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Recently, we showed that truncation of the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene caused mental retardation and severe neurological symptoms in two female patients. Here, we report that de novo missense mutations in CDKL5 are associated with a severe phenotype of early-onset infantile spasms and clinical features that overlap those of other neurodevelopmental disorders, such as Rett syndrome and Angelman syndrome. The mutations are located within the protein kinase domain and affect highly conserved amino acids; this strongly suggests that impaired CDKL5 catalytic activity plays an important role in the pathogenesis of this neurodevelopmental disorder. In view of the overlapping phenotypic spectrum of CDKL5 and MECP2 mutations, it is tempting to speculate that these two genes play a role in a common pathogenic process.
引用
收藏
页码:1149 / 1154
页数:6
相关论文
共 28 条
[1]   Rett syndrome:: Clinical manifestations in males with MECP2 mutations [J].
Ben Zeev, B ;
Yaron, Y ;
Schanen, NC ;
Wolf, H ;
Brandt, N ;
Ginot, N ;
Shomrat, R ;
Orr-Urtreger, A .
JOURNAL OF CHILD NEUROLOGY, 2002, 17 (01) :20-24
[2]   A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients [J].
Bourdon, V ;
Philippe, C ;
Labrune, O ;
Amsallem, D ;
Arnould, C ;
Jonveaux, P .
HUMAN GENETICS, 2001, 108 (01) :43-50
[3]   Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene:: Identification of several novel mutations and polymorphisms [J].
Buyse, IM ;
Fang, P ;
Hoon, KT ;
Amir, RE ;
Zoghbi, HY ;
Roa, BB .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (06) :1428-1436
[4]   Activation mechanism of the MAP kinase ERK2 by dual phosphorylation [J].
Canagarajah, BJ ;
Khokhlatchev, A ;
Cobb, MH ;
Goldsmith, EJ .
CELL, 1997, 90 (05) :859-869
[5]   Identification of MeCP2 mutations in a series of females with autistic disorder [J].
Carney, RM ;
Wolpert, CM ;
Ravan, SA ;
Shahbazian, M ;
Ashley-Koch, A ;
Cuccaro, ML ;
Vance, JM ;
Pericak-Vance, MA .
PEDIATRIC NEUROLOGY, 2003, 28 (03) :205-211
[6]   Long-read sequence analysis of the MECP2 gene in Rett syndrome patients:: correlation of disease severity with mutation type and location [J].
Cheadle, JP ;
Gill, H ;
Fleming, N ;
Maynard, J ;
Kerr, A ;
Leonard, H ;
Krawczak, M ;
Cooper, DN ;
Lynch, S ;
Thomas, N ;
Hughes, H ;
Hulten, M ;
Ravine, D ;
Sampson, JR ;
Clarke, A .
HUMAN MOLECULAR GENETICS, 2000, 9 (07) :1119-1129
[7]   Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2 [J].
Chen, WG ;
Chang, Q ;
Lin, YX ;
Meissner, A ;
West, AE ;
Griffith, EC ;
Jaenisch, R ;
Greenberg, ME .
SCIENCE, 2003, 302 (5646) :885-889
[8]   MECP2 is highly mutated in X-linked mental retardation [J].
Couvert, P ;
Bienvenu, T ;
Aquaviva, C ;
Poirier, K ;
Moraine, C ;
Gendrot, C ;
Verloes, A ;
Andrès, C ;
Le Fevre, AC ;
Souville, I ;
Steffann, J ;
des Portes, V ;
Ropers, HH ;
Yntema, HG ;
Fryns, JP ;
Briault, S ;
Chelly, J ;
Cherif, B .
HUMAN MOLECULAR GENETICS, 2001, 10 (09) :941-946
[9]  
GOUTIERES F, 1986, AM J MED GENET, V24, P183
[10]   A PROGRESSIVE SYNDROME OF AUTISM, DEMENTIA, ATAXIA, AND LOSS OF PURPOSEFUL HAND USE IN GIRLS - RETTS SYNDROME - REPORT OF 35 CASES [J].
HAGBERG, B ;
AICARDI, J ;
DIAS, K ;
RAMOS, O .
ANNALS OF NEUROLOGY, 1983, 14 (04) :471-479